https://www.oncologynurseadvisor.com Thu, 04 Jan 2024 20:09:40 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/elotuzumab-krd-newly-diagnosed-multiple-myeloma-improves/ Tue, 20 Jun 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=108532 Adding elotuzumab to carfilzomib, lenalidomide, and dexamethasone leads to deeper remissions in transplant-eligible, newly diagnosed multiple myeloma, data suggest.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/talazoparib-atezolizumab-maintenance-slfn11-es-sclc-improves-pfs/ Tue, 20 Jun 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108534 Adding talazoparib to atezolizumab maintenance can improve progression-free survival in patients with SLFN11+ extensive-stage small cell lung cancer, a phase 2 trial suggests.]]> https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/zanidatamab-her2-biliary-tract-cancer-yields-durable-responses/ Thu, 08 Jun 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108166 Zanidatamab can produce rapid and durable responses in patients with advanced HER2-positive biliary tract cancer, phase 2 data suggest. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/use-of-anti-inflammatory-analgesics-has-a-positive-effect-on-survival-outcomes-in-ovarian-cancer/ Thu, 13 Sep 2018 19:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/use-of-anti-inflammatory-analgesics-has-a-positive-effect-on-survival-outcomes-in-ovarian-cancer/ The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.]]> https://www.oncologynurseadvisor.com/home/cancer-types/myeloproliferative-neoplasms/myeloablative-conditioning-effective-in-aml-secondary-to-mds-mpn-prior-to-allogeneic-hct/ Thu, 13 Sep 2018 15:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/myeloablative-conditioning-effective-in-aml-secondary-to-mds-mpn-prior-to-allogeneic-hct/ In the EBMT ALWP study, researchers sought to determine the efficacy of myeloablative conditioning to reduce the risk for post allogeneic HCT in patients with sAML without significantly increasing non-relapse mortality.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/pulmonary-toxicity-increased-in-pediatric-hodgkin-lymphoma-treated-with-brentuximab-vedotin/ Thu, 13 Sep 2018 13:30:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/pulmonary-toxicity-increased-in-pediatric-hodgkin-lymphoma-treated-with-brentuximab-vedotin/ A retrospective study evaluated the efficacy vs pulmonary toxicity of brentuximab vedotin for relapsed or refractory Hodgkin lymphoma in pediatric patients.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/social-support-is-biggest-determinant-of-life-satisfaction-for-adolescents-with-cancer/ Wed, 12 Sep 2018 14:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/social-support-is-biggest-determinant-of-life-satisfaction-for-adolescents-with-cancer/ Using the Questions on Life Satisfaction (FLZ-M) questionnaire, researchers determined the extent of life satisfaction across 10 subdomains reported by adolescents and young adults with cancer.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/rituximab-maintenance-improved-long-term-survival-in-elderly-with-follicular-lymphoma/ Tue, 11 Sep 2018 18:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/rituximab-maintenance-improved-long-term-survival-in-elderly-with-follicular-lymphoma/ A retrospective analysis of outcomes demonstrated the influence of rituximab maintenance after R-CHOP or R-CVP for follicular lymphoma in elderly patients.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/insurance-status-influences-overall-survival-in-follicular-lymphoma/ Tue, 11 Sep 2018 15:30:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/insurance-status-influences-overall-survival-in-follicular-lymphoma/ Outcomes data demonstrated the impact of socioeconomic status and insurance coverage on outcomes for patients with follicular lymphoma by age (younger than 65 and 65 and older).]]> https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/too-much-physical-activity-during-therapy-for-pediatric-all-decreases-cognitive-function/ Fri, 07 Sep 2018 15:30:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/too-much-physical-activity-during-therapy-for-pediatric-all-decreases-cognitive-function/ Using a longitudinal parallel-process model, researchers evaluated the impact of physical activity on symptoms, physical activity, and cognitive function in children with ALL undergoing chemotherapy.]]>